Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGPhase 1 / Phase 2INTERVENTIONAL

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.

Who May Be Eligible (Plain English)

Who May Qualify: - Provide written willing to sign a consent form - Ability to hold gaze sufficiently stable for study testing - Willingness and ability to follow all instructions and comply with schedule for follow-up visits - Have a diagnosis of keratoconus Who Should NOT Join This Trial: - Known allergy or sensitivity to the test articles or components - Any disease causing abnormal topography other than keratoconus - Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Provide written informed consent * Ability to hold gaze sufficiently stable for study testing * Willingness and ability to follow all instructions and comply with schedule for follow-up visits * Have a diagnosis of keratoconus Exclusion Criteria: * Known allergy or sensitivity to the test articles or components * Any disease causing abnormal topography other than keratoconus * Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications

Treatments Being Tested

COMBINATION_PRODUCT

NXL Energy 1

Riboflavin drops + NXL System to Total Energy Level 1

COMBINATION_PRODUCT

NXL Energy 2

Riboflavin drops + NXL System to Total Energy Level 2

COMBINATION_PRODUCT

NXL Energy 3

Riboflavin drops + NXL System to Total Energy Level 3

COMBINATION_PRODUCT

Sham Treatment

Sham Drops and No exposure to NXL system

Locations (3)

Glaukos Investigative Site
Dothan, Alabama, United States
Glaukos Investigative Site
Teaneck, New Jersey, United States
Glaukos Investigative Site
Westerville, Ohio, United States